Phase 1/2 study of S-288310 in patients with bladder cancer

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080220948

Enrollment

Registered

2009-12-25

Start date

2009-12-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder cancer

Interventions

investigational material(s) Generic name etc : S-288310 INN of investigational material : Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with recurrent bladder cancer after total cystectomy or with unresectable bladder cancer

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Safety and efficacy	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026